Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC K-Dur Case Incorrectly Defines Market, Judge Says In Ruling For Schering

Executive Summary

Merck-Medco's decision not to separately list Schering-Plough's K-Dur on its formulary is evidence that the drug is therapeutically substitutable and competes with other versions of potassium chloride, an administrative law judge said
Advertisement

Related Content

“Reverse” Payments Anti-Competitive In K-Dur Pact But Not All Cases – FTC
“Reverse” Payments Anti-Competitive In K-Dur Pact But Not All Cases – FTC
K-Dur Case: Reverse Payments Not “Established” Antitrust Violations – Judge
K-Dur Case: Reverse Payments Not “Established” Antitrust Violations – Judge
K-Dur Case: Reverse Payments Not “Established” Antitrust Violations – Judge
AHP K-Dur Settlement With FTC Applies To Brand And Generic Divisions
Upsher Launches K-Dur Generic With Exclusivity; FTC Hearing In December
FTC K-Dur Suit Would Allow Andrx Generic Launch; FDA Could Act First
FTC K-Dur Suit Would Allow Andrx Generic Launch; FDA Could Act First
Advertisement
UsernamePublicRestriction

Register

PS040121

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel